We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
GLOFITAMAB MONOTHERAPY INDUCES DURABLE COMPLETE REMISSIONS AND HAS A MANAGEABLE SAFETY PROFILE IN PATIENTS WITH RICHTER'S TRANSFORMATION.
- Authors
Carlo‐Stella, C.; Hutchings, M.; Offner, F.; Mulvihill, E.; Relf, J.; Byrne, B.; Lundberg, L.; Dickinson, M.
- Abstract
B Introduction: b Richter's transformation (RT) is characterized by transformation of chronic lymphocytic leukemia to an aggressive lymphoma, most commonly CD20+ large B-cell lymphoma (LBCL). B Conclusions: b Fixed-duration glofitamab monotherapy induces durable complete remissions and has a manageable safety profile in pts with RT.
- Subjects
PATIENT safety; RICHTER syndrome; CYTOKINE release syndrome; CHRONIC lymphocytic leukemia
- Publication
Hematological Oncology, 2023, Vol 41, p63
- ISSN
0278-0232
- Publication type
Article
- DOI
10.1002/hon.3163_28